1
|
Hodgson H, Davidson D, Duncan A, Guthrie J, Henderson E, MacDiarmid M, McGown K, Pollard V, Potter R, Rodgers A, Wilson A, Horner J, Doran M, Simm S, Taylor R, Rogers A, Rippon MG, Colgrave M. A multicentre, clinical evaluation of a hydro-responsive wound dressing: the Glasgow experience. J Wound Care 2019; 26:642-650. [PMID: 29131748 DOI: 10.12968/jowc.2017.26.11.642] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/22/2023]
Abstract
OBJECTIVE Our aim was to assess the effectiveness of hydro-responsive wound dressing (HRWD) in debridement and wound bed preparation of a variety of acute and chronic wounds that presented with devitalised tissue needing removal so that healing may proceed. METHOD This was a non-comparative evaluation of acute and chronic wounds that required debridement as part of their normal treatment regimen. Clinicians recorded wound changes including a subjective assessment level of devitalised tissue and wound bed preparation, presence of pain, wound status (e.g., wound size) and periwound skin condition. Data was also collected from clinicians and patients to provide information on clinical performance of the dressing. RESULTS We recruited 100 patients with a variety of wound types into the study. Over 90% of the clinicians reported removal of devitalised tissue to enable a healing response in both chronic and acute wounds. Specifically, over the course of the evaluation period, levels of devitalised tissue (necrosis and slough) reduced from 85.5% to 26.3%, and this was accompanied by an increase in wound bed granulation from 12.0% to 33.7%. Correspondingly, there was a 40% reduction in wound area, hence a clinically relevant healing response was seen upon treatment with HRWD. It is also noteworthy that this patient population included a significant proportion of chronic wounds (51.4%) that showed no signs of wound progression within <4 weeks before study inclusion. Of these chronic wounds, 93% demonstrated wound progression upon treatment with HRWD. Despite reported pain levels being low pre- and post-dressing change, overall wound pain improved (reduced) in 48% of patients. Periwound skin condition showed a tendency towards improvement, and the fluid management capabilities of the HRWD was reported as good to excellent in the majority of cases. Wound infections were reduced by at least 60% over the evaluation period. A simple cost-effective analysis demonstrated significant savings using HRWD (£6.33) over current standard practice regimens of a four-step debridement process (£8.05), larval therapy (£306.39) and mechanical pad debridement (£11.46). CONCLUSION HRWD was well tolerated and was demonstrated to be an efficient debridement tool providing rapid, effective and pain free debridement in a variety of wound types.
Collapse
Affiliation(s)
- H Hodgson
- Lead Investigator, Lead Nurse Tissue Viability, Tissue Viability Acute and Partnerships, Glasgow
| | - D Davidson
- Vascular Nurse Specialist, Inverclyde Royal Hospital, Greenock
| | - A Duncan
- Vascular Nurse Specialist, Queen Elizabeth University Hospital, Glasgow
| | - J Guthrie
- Tissue Viability Specialist Nurse, Tissue Viability Acute and Partnerships, Glasgow
| | - E Henderson
- Tissue Viability Nurse Specialist, Glasgow Royal Infirmary, Glasgow
| | - M MacDiarmid
- Tissue Viability Clinical Nurse Specialist, Queen Elizabeth University Hospital, Glasgow
| | - K McGown
- Tissue Viability Nurse, Queen Elizabeth University Hospital, Glasgow
| | - V Pollard
- Tissue Viability Nurse, Inverclyde Royal Hospital, Greenock
| | - R Potter
- Tissue Viability Clinical Nurse Specialist, Tissue Viability Specialist Nurses (Partnerships Glasgow)
| | - A Rodgers
- Paediatric Tissue Viability Nurse, Royal Hospital for Children, Glasgow
| | - A Wilson
- Tissue Viability Nurse Specialist, Royal Alexandra Hospital, Paisley
| | - J Horner
- Tissue Viability Personal Assistant, Tissue Viability Acute and Partnerships, Glasgow
| | - M Doran
- Tissue Viability Personal Assistant, Tissue Viability Acute and Partnerships, Glasgow
| | - S Simm
- Clinical Development Manager, Hartmann Wound Care, Haywood, Lancashire
| | - R Taylor
- Nurse Advisor (North), Hartmann Wound Care, Haywood, Lancashire
| | - A Rogers
- Medical Communications, Flintshire, North Wales
| | - M G Rippon
- Visiting Clinical Research Fellow, Huddersfield University, Queensgate, Huddesfield
| | - M Colgrave
- Freelance Medical Writer, Molecular Cell Research, Lincoln
| |
Collapse
|
2
|
McGown K, Tunney M, McGrath S, Elborn J, Gilpin D. S22 The Effect Of Cigarette Smoke On Important Pathogens In Copd Lung Infection. Thorax 2014. [DOI: 10.1136/thoraxjnl-2014-206260.28] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|